CaDo Biotechnology IvS: Financial statements 2019
CVR: 38777815
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CaDo Biotechnology IvS (CVR 38777815) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 21,060 and a net result of DKK 19,916. Equity in the 2019 report amounted to DKK 29,701. The solvency ratio was 91%.
- Gross Profit
- DKK 21,060
- Profit/Loss
- DKK 19,916
- Equity
- DKK 29,701
- Total Assets
- DKK 32,654
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CaDo Biotechnology IvS has published its interim report for the period July 1, 2017 to December 31, 2018.
About CaDo Biotechnology IvS
CaDo Biotechnology IvS was a Danish company of the type Iværksætterselskab based in Birkerød, founded in 2017. The company has been dissolved on 17 June 2020. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2019, the company reported a gross profit of DKK 21,060 and a net result of DKK 19,916. Equity in the 2019 report amounted to DKK 29,701.